Medical News Today: Cancer drug shows promise in Parkinson’s disease safety trial
Nilotinib, a drug that regulators have approved for the treatment of leukemia, has shown promise in a small clinical trial of people with Parkinson’s disease. Share on PinterestAn approved leukemia drug holds promise for the treatment of Parkinson’s. The main purpose of the trial was to assess the repurposed drug’s safety and tolerability and how…
Details